10x Genomics, Inc. (TXG) operating KPIs
TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30160% above fair value
$70.11−11.44 (-14.03%)
Close on Oct 30, 2026Market cap $9.13BP/E –Yield –
KPIs
Operating metrics that drive 10x Genomics's business
Coming soon
This tab will track the numbers specific to 10x Genomics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.